← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
CGTBiologicstaleMemorial Sloan Kettering Cancer…Phase 1

EGFRt/BCMA-41BBz CAR T cell (EGFRt/BCMA-41BBz CAR T cell)

Multiple Myeloma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleDaniel LandiPhase 1

EGFRvIII CAR T cells (EGFRvIII CAR T cells)

Glioblastoma; Gliosarcoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 0%임상시험 1상태 DISCONTINUED
CGTBiologicstaleGary Archer Ph.D.Phase 1

EGFRvIII-CARs (EGFRvIII-CARs)

Recurrent Glioblastoma; Recurrent Gliosarcoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 0%임상시험 1상태 DISCONTINUED
ADCBiologicstaleEisbach Bio GmbHPhase 2

EIS-12656 (EIS-12656)

Advanced Solid Tumor; Homologous Recombination Deficiency · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of ArkansasPhase 2

ENK Cell Infusion (ENK Cell Infusion)

Asymptomatic Multiple Myeloma · Asymptomatic Multiple Myeloma

#AsymptomaticMultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
ADCBiologicstaleHummingbird BiosciencePhase 2

ENV-501 (ENV-501)

Melanoma (Skin); Non Small Cell Lung Cancer · Melanoma (Skin)

#MelanomaSkin#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleElevation OncologyPhase 1

EO-3021 (EO-3021)

Stomach Neoplasm; Gastrointestinal Neoplasms · Stomach Neoplasm

#StomachNeoplasm#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 1%임상시험 1상태 DISCONTINUED
CGTBiologicstaleZhejiang UniversityPhase 1

EPCAM CAR-T (EPCAM CAR-T)

Advanced Hepatocellular Carcinoma; Advanced Colorectal Cancer · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleSinobioway Cell Therapy Co., Lt…Preclinical

EPCAM-targeted CAR-T cells (EPCAM-targeted CAR-T cells)

Stomach Neoplasms · Liver Neoplasms

#LiverNeoplasms#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleAmgenPhase 3

nivolumab (Opdivo, EU-authorized Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

Herceptin® (EU-sourced Trastuzumab, EU-sourced Trastuzumab (Herceptin®))

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleEutilexPhase 1

EU307 CAR-T Cell (EU307 CAR-T Cell)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

EZN-2208, Cetuximab and Irinotecan (EZN-2208, Cetuximab and Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, Early treatment of relapse with carfilzomib, dexamethasone, daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAstraZeneca Rare DiseaseApproved

Eculizumab+IVMP (Eculizumab+IVMP)

Neuromyelitis Optica Spectrum Disorder Attack · Neuromyelitis Optica Spectrum Disorder A

#NeuromyelitisOpticaSpectrumDisor#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing Boren HospitalPhase 1

Efficacy of LCAR-T2C CAR-T cells (Efficacy of LCAR-T2C CAR-T cells)

T Cell Lymphoma; T-cell Leukemia · T Cell Lymphoma

#TCellLymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleChinese PLA General HospitalPhase 2

Eliglustat, CD30 target immunotherapy (Eliglustat, CD30 target immunotherapy)

Lymphoma · CD30

#CD30#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleUniversity of Illinois at Chica…Phase 3

Elra (Elranatamab, Elranatamab (Elra))

Plasmablastic Lymphoma; Hiv · Plasmablastic Lymphoma

#PlasmablasticLymphoma#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystalePfizerPhase 2

Elranatamab + Nirogacestat (Elranatamab + Nirogacestat)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleWashington University School of…Phase 2

Elrantamab (Elrantamab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

111 / 177 페이지

← 이전다음 →